Michael Brooks
Chief Operating Officer bei SYNEOS HEALTH, INC.
Aktive Positionen von Michael Brooks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYNEOS HEALTH, INC. | Chief Operating Officer | 29.04.2022 | - |
Corporate Officer/Principal | 14.07.2021 | 29.04.2022 | |
North Carolina State University College of Sciences Foundation | Director/Board Member | - | - |
Karriereverlauf von Michael Brooks
Ehemalige bekannte Positionen von Michael Brooks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
COVANCE INC. | Corporate Officer/Principal | 01.12.2018 | 01.11.2019 |
President | 01.11.2019 | 01.11.2020 | |
PRA HEALTH SCIENCES, INC. | Corporate Officer/Principal | 01.02.2015 | 01.11.2018 |
LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - | - |
Ausbildung von Michael Brooks
North Carolina State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 3 |
Health Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
Private Unternehmen | 4 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
PRA Health Sciences, Inc.
PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights, and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. | Commercial Services |
North Carolina State University College of Sciences Foundation | |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
- Börse
- Insiders
- Michael Brooks
- Erfahrung